- Home
- USEA vs SCNX Comparison
USEA vs SCNX Comparison
Compare USEA & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.61
HOLD
Current Price
$0.39
Company Overview
Basic Information| Metric | USEA | SCNX |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | Greece | United States |
| Employees | N/A | 19 |
| Industry | Marine Transportation | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7M | 19.0M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | USEA | SCNX |
|---|---|---|
| Price | $2.61 | $0.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 71.4K | ★ 337.2K |
| Earning Date | 05-21-2026 | 05-13-2026 |
| Dividend Yield | ★ 11.22% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.55 | $1,097.38 |
| Revenue Next Year | $4.60 | $239.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.42 | $0.24 |
| 52 Week High | $2.75 | $2.60 |
Technical Indicators
Market Signals| Indicator | USEA | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 61.65 | 51.71 |
| Support Level | $1.62 | $0.38 |
| Resistance Level | N/A | $0.43 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 62.90 | 66.67 |
Price Performance
Historical Comparison USEA
SCNX
About USEA United Maritime Corporation
United Maritime Corp is an international shipping company currently specializing in world-wide seaborne transportation services. It currently operates a fleet of dry bulk vessels, comprising Panamax, Capesize and Kamsarmax vessels. Its vessels include Dukeship, Nisea, Cretansea, Chrisea, Synthesea, and Exelixsea.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.